ArticleAmerican journal of physiology. Heart and circulatory physiology2026
3D echo derived right ventricular principal surface strain in pulmonary arterial hypertension.
Hannah Takahashi Oakland, Lavanya Bellumkonda, Lissa Sugeng, Phillip Joseph, Priyamvada Kundu, Daniel Izzi, Felica Zalik, Shannon McCabe, Amjad Raza, Ray Amendola and 3 more
Abstract read
In one paragraphArticle in American journal of physiology. Heart and circulatory physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Hannah Takahashi OaklandDivision of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, Emory University, Atlanta, Georgia, United States.ORCID 0000-0003-4678-1554 Lavanya BellumkondaSection of Cardiovascular Medicine, Department of Internal Medicine, Yale University, New Haven, Connecticut, United States.
Lissa SugengSection of Cardiovascular Medicine, Department of Internal Medicine, Yale University, New Haven, Connecticut, United States.
Phillip JosephSection of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale University, New Haven, Connecticut, United States.ORCID 0000-0001-9299-8629 Priyamvada KunduMedtronic, Boston, Massachusetts, United States.
Daniel IzziHeart and Vascular Center, Yale New Haven Hospital, New Haven, Connecticut, United States.
Felica ZalikMedtronic, Boston, Massachusetts, United States.
Shannon McCabeHeart and Vascular Center, Yale New Haven Hospital, New Haven, Connecticut, United States.
Amjad RazaHeart and Vascular Center, Yale New Haven Hospital, New Haven, Connecticut, United States.
Ray AmendolaHeart and Vascular Center, Yale New Haven Hospital, New Haven, Connecticut, United States.
Paul M HeerdtDepartment of Anesthesiology, Yale Medical School, New Haven, Connecticut, United States.ORCID 0000-0002-9765-9885 Kendall S HunterDepartment of Bioengineering, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States.ORCID 0000-0002-5162-8100 Inderjit SinghSection of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale University, New Haven, Connecticut, United States.ORCID 0000-0001-5624-1274 Funding
Training Translational Lung Biology and PathobiologyT32HL007778 · NHLBI · YALE UNIVERSITY · PI Erica L Herzog, NAFTALI KAMINSKI · 1994 to 2026
$14.4MCardiorespiratory Pharmacodynamics of Fentanyl-XylazineR21DA061073 · NIDA · YALE UNIVERSITY · PI HEERDT, PAUL MARK · 2024 to 2025
$461kSecondary Analysis of 3D Echo Images of the Right Ventricle to Compute 3D Surface StrainR21HL177693 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Kendall Stephen Hunter · 2025 to 2026
$234kHHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) 5T32HL007778-25HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) NIH R21HL177693HHS | NIH | National Institute on Drug Abuse (NIDA) NIH 1R21DA061073-01NHLBI NIH HHS R21 HL177693NHLBI NIH HHS T32 HL007778NIDA NIH HHS R21 DA061073
6 · The paper itselfAbstract
Traditional echocardiographic metrics of right ventricular (RV) function, including tricuspid annular plane systolic excursion and two-dimensional (2-D) strain, are limited to the description of longitudinal systolic function. These metrics, however, fail to account for the complex, three-dimensional (3-D) deformation of the RV. 3-D echocardiograms (3DE) were obtained simultaneously during clinically indicated right heart catheterization (RHC). We determined the maximum principal surface strain (PS
Indexed as
Echocardiography, Three-DimensionalHeart FailureHeart VentriclesHypertension, PulmonaryPulmonary Arterial HypertensionVentricular Dysfunction, RightVentricular Function, RightAdultCardiac CatheterizationCase-Control StudiesFemaleGlobal Longitudinal StrainHumansMaleMiddle AgedPredictive Value of Testsright heart failureright ventricular remodelingTAPSEventricular remodeling
Identifiers
PMID41616802
PMCPMC13097151
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390